CompletedPhase 3NCT01638403

Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.

Studying Narcolepsy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bioprojet
Principal Investigator
DAUVILLIERS Yves
Hôpital Gui de Chauliac - 80, avenue A. Fliche , 34295 Montpellier cedex 5 - FRANCE
Intervention
BF2.649(drug)
Enrollment
180 enrolled
Eligibility
18 years · All sexes
Timeline
20102012

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01638403 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy

← Back to all trials